Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May;121(5):879-885.
doi: 10.1016/j.jfma.2021.10.001. Epub 2021 Oct 8.

The effectiveness of mouthwash against SARS-CoV-2 infection: A review of scientific and clinical evidence

Ming-Hsu Chen  1 , Po-Chun Chang  2
Affiliations
Review

The effectiveness of mouthwash against SARS-CoV-2 infection: A review of scientific and clinical evidence

Ming-Hsu Chen et al. J Formos Med Assoc. 2022 May.

Abstract

The COVID-19 pandemic, caused by the spread of SARS-CoV-2 infection that is mainly through the airborne transmission, is a worldwide health concern. This review seeks to assess the potential effectiveness of mouthwash in reducing the oropharyngeal load of SARS-CoV-2 based on the available evidence. Articles related to mouthwash and COVID-19 in PubMed were electronically searched in July, 2021. After manually excluding articles lacking sufficient scientific evidence or validation processes, those with inaccessible online full text, those that did not test the effectiveness of mouthwash against SARS-CoV-2, and those not written in English, 17 original and 13 review articles were chosen for this review. The eligible articles revealed that the main virucidal mechanism of mouthwash was via interactions with the viral envelope. Povidone-iodine (PVP-I), cetylpyridinium chloride (CPC), and essential oils with ethanol showed virucidal effects on SARS-CoV-2 in vitro, potentially by interfering with the viral envelope. A few clinical studies demonstrated that PVP-I, CPC, hydrogen peroxide, and chlorhexidine reduced the oropharyngeal load of SARS-CoV-2. Although the available evidence is limited, mouthwash containing PVP-I or CPC shows potential for reducing the oropharyngeal load of SARS-CoV-2 and thus may present a risk-mitigation strategy for COVID-19 patients.

Keywords: COVID-19; Cetylpyridinium chloride; Chlorhexidine; Mouthwashes; Povidone-iodine.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors have no conflicts of interest relevant to this article.

References

    1. WHO coronavirus (COVID-19) dashboard. https://covid19.who.int/
    1. Liu J., Liao X., Qian S., Yuan J., Wang F., Liu Y., et al. Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis. 2020;26:1320–1323. - PMC - PubMed
    1. Zou L., Ruan F., Huang M., Liang L., Huang H., Hong Z., et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382:1177–1179. - PMC - PubMed
    1. To K.K., Tsang O.T., Yip C.C., Chan K.H., Wu T.C., Chan J.M., et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020;71:841–843. - PMC - PubMed
    1. Xu H., Zhong L., Deng J., Peng J., Dan H., Zeng X., et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12:8. - PMC - PubMed